A rare brain tumor in one child showed two gene changes
Original title: Myxoid glioneuronal tumor of the septum pellucidum with concurrent dual PDGFRA and FGFR3 gene mutations: a case report and literature review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This describes one child and past reports, and no treatment was tested.
The short version
Doctors found an unusual gene pattern in one child's rare, slow-growing brain tumor.
What was studied. Doctors described one 10-year-old girl who had headaches. They found a rare tumor in the middle of her brain. They also looked back at past reports of this tumor type.
What they found. Surgeons removed all of the tumor they could see. Gene tests found changes in two genes, called PDGFRA and FGFR3. This tumor type is usually slow-growing and often has a good outlook, but in rare cases it has spread.
What this means, and what it doesn't
What it could mean: Gene testing may help doctors name this tumor type more exactly and judge its risk. The second gene change might one day point to a new drug to try for some patients.
What it doesn't mean: This is a report about one child, not a treatment study. No new drug was tested here. Any drug aimed at this gene change would need much more study first. This is not a cure and will not change care today.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.